FYI, the previous version of Wheezo has already received FDA approval, the issue will always be a $99.50 for a device that only monitor for wheeze with a limited market demographic for children under 14, globally RSH will have the same slow uptake as in Australia, IMO.
chart, page-1079
-
- There are more pages in this discussion • 1,066 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RSH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $72.29M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 103328 | 5.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.3¢ | 30000 | 1 |
View Market Depth
| Last trade - 16.12pm 11/10/2024 (20 minute delay) ? |
| RSH (ASX) Chart |
Day chart unavailable